Biocodex is a multinational pharmaceutical company that focuses on researching, developing, and marketing products that meet the needs of both healthcare professionals and patients worldwide. Their main areas of expertise are in gastroenterology, neurology, and oncology.
Biocodex was founded in 1953 in France.
Their first product was Florastor®, a probiotic used to treat gastrointestinal disorders.
In the 1970s, Biocodex expanded to other countries, starting with Spain and then moving to Italy, Portugal, and beyond.
In the 2000s, they began to expand into neurology and oncology, and now have a range of products in those areas as well as gastroenterology.
Bayer is a multinational pharmaceutical company that develops products across a wide range of therapeutic areas, including gastroenterology and neurology. They are headquartered in Germany.
Pfizer is a multinational pharmaceutical company that develops and sells products in multiple therapeutic areas, including gastroenterology and neurology. They are headquartered in the US.
Takeda is a multinational pharmaceutical company that specializes in gastroenterology, oncology, and other areas. They are headquartered in Japan.
Florastor is a probiotic used to treat gastrointestinal disorders, such as diarrhea. It is available in various forms, including capsules and powder.
Duspatalin is an antispasmodic medication used to treat gastrointestinal disorders, such as irritable bowel syndrome. It is available in tablet form.
Uromitexan is a medication used to prevent and treat bladder inflammation caused by the chemotherapy drug cyclophosphamide. It is available in injectable form.
Biocodex develops products in gastroenterology, neurology, and oncology, including probiotics, antispasmodic medications, and drugs used to prevent bladder inflammation.
Biocodex is headquartered in France.
Florastor is a probiotic developed by Biocodex that is used to treat gastrointestinal disorders, such as diarrhea.
Biocodex's competitors include Bayer, Pfizer, and Takeda, among others.
Yes, Biocodex has developed products for neurological disorders, such as epilepsy and multiple sclerosis.
